Scherer SS - Search Results

1

Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.

Kleopa KA, Elman LB, Lang B, Vincent A, Scherer SS. Kleopa KA, et al. Among authors: scherer ss. Brain. 2006 Jun;129(Pt 6):1570-84. doi: 10.1093/brain/awl084. Epub 2006 Apr 13. Brain. 2006. PMID: 16613892

2

Cellular mechanisms of connexin32 mutations associated with CNS manifestations.

Kleopa KA, Yum SW, Scherer SS. Kleopa KA, et al. Among authors: scherer ss. J Neurosci Res. 2002 Jun 1;68(5):522-34. doi: 10.1002/jnr.10255. J Neurosci Res. 2002. PMID: 12111842

3

Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems.

Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL. Altevogt BM, et al. Among authors: scherer ss. J Neurosci. 2002 Aug 1;22(15):6458-70. doi: 10.1523/JNEUROSCI.22-15-06458.2002. J Neurosci. 2002. PMID: 12151525 Free PMC article.

4

Inherited neuropathies.

Kleopa KA, Scherer SS. Kleopa KA, et al. Among authors: scherer ss. Neurol Clin. 2002 Aug;20(3):679-709. doi: 10.1016/s0733-8619(01)00016-0. Neurol Clin. 2002. PMID: 12432826 Review.

5

KCNQ2 is a nodal K+ channel.

Devaux JJ, Kleopa KA, Cooper EC, Scherer SS. Devaux JJ, et al. Among authors: scherer ss. J Neurosci. 2004 Feb 4;24(5):1236-44. doi: 10.1523/JNEUROSCI.4512-03.2004. J Neurosci. 2004. PMID: 14762142 Free PMC article.

6

Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes.

Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS. Kleopa KA, et al. Among authors: scherer ss. Glia. 2004 Sep;47(4):346-57. doi: 10.1002/glia.20043. Glia. 2004. PMID: 15293232

7

Molecular genetics of X-linked Charcot-Marie-Tooth disease.

Kleopa KA, Scherer SS. Kleopa KA, et al. Among authors: scherer ss. Neuromolecular Med. 2006;8(1-2):107-22. doi: 10.1385/nmm:8:1-2:107. Neuromolecular Med. 2006. PMID: 16775370 Review.

8

Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants.

Sargiannidou I, Ahn M, Enriquez AD, Peinado A, Reynolds R, Abrams C, Scherer SS, Kleopa KA. Sargiannidou I, et al. Among authors: scherer ss. Neurobiol Dis. 2008 May;30(2):221-33. doi: 10.1016/j.nbd.2008.01.009. Epub 2008 Feb 15. Neurobiol Dis. 2008. PMID: 18353664 Free PMC article.

9

Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects.

Sargiannidou I, Vavlitou N, Aristodemou S, Hadjisavvas A, Kyriacou K, Scherer SS, Kleopa KA. Sargiannidou I, et al. Among authors: scherer ss. J Neurosci. 2009 Apr 15;29(15):4736-49. doi: 10.1523/JNEUROSCI.0325-09.2009. J Neurosci. 2009. PMID: 19369543 Free PMC article.

10

A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1B.

Lancaster E, Elman LB, Scherer SS. Lancaster E, et al. Among authors: scherer ss. Muscle Nerve. 2010 Apr;41(4):555-8. doi: 10.1002/mus.21546. Muscle Nerve. 2010. PMID: 19918771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters